Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
Target Locked in gMG: Why T2T Matters
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
The 2-Point Signal: Apply ≥2-Point Rule
When to Begin FcRn: Initiation Criteria, Key Evidence
Escalate With Intention: Stepwise, Target-Anchored Moves
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Turning Flares Into Function: Flag Uncontrolled Disease
The IgG Clock: Redose Using IgG Kinetics
Shared Goals, Shared Gains: Align With Patient Preferences
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Lee P. Shulman, MD, FACMG, FACOG
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Minimal By Design: Define MSE Endpoints
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Alloimmune Neutropenia of the Fetus and Newborn
Masja de Haas, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Clinical Considerations for the Diagnosis of Endometriosis
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.